Spis treści:
Spis załączników:
Litigation_relating_to_esomeprazole_product_in_Denmark.pdf (REPORT)
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
Litigation_relating_to_esomeprazole_product_in_Denmark.pdf (REPORT)
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| UNI - EN REPORT No | 11 | / | 2013 | ||||||||
| Date of issue: | 2013-04-11 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Litigation relating to esomeprazole product in Denmark | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne |
|||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| The document is attached. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Litigation relating to esomeprazole product in Denmark.pdfLitigation relating to esomeprazole product in Denmark.pdf | esomeprazol, litigation | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) |
||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2013-04-11 | Jože Colarič | President of the Management Board | |||
Źródło:Komunikaty spółek (ESPI)
